Charter Oak Partners

Charter Oak Partners is a private investment firm based in Westport, Connecticut, that has played a historically significant role in the growth of the biotechnology industry. Founded in 1992, the firm is best known for its early and influential investments in foundational life science companies such as Amgen, Genzyme, Regeneron, and Centocor. While it operates as an investment vehicle rather than a therapeutic developer, its strategic capital and long-term investment horizon were instrumental in the commercialization of early recombinant DNA technologies and orphan drug development. Today, the firm continues to manage private capital with a focus on high-growth sectors, including healthcare and technology, often through its successor and affiliate entities.